1、 ChinaAMC Leveraged/Inverse Series ChinaAMC NASDAQ-100 Index Daily(2x)Leveraged Product ChinaAMC NASDAQ-100 Index Daily(-2x)Inverse Product Unaudited Semi-Annual Report For the period from 1 January 2025 to 30 June 2025 UNAUDITED SEMI ANNUAL REPORT CHINAAMC NASDAQ-100 INDEX DAILY(2x)LEVERAGED PRODUC
2、T(Stock Code:7261(USD counter)CHINAAMC NASDAQ-100 INDEX DAILY(-2x)INVERSE PRODUCT (Stock Code:7522(USD counter)FOR THE PERIOD FROM 1 JANUARY 2025 TO 30 JUNE 2025 (PRODUCTS OF CHINAAMC LEVERAGED/INVERSE SERIES)CHINAAMC LEVERAGED/INVERSE SERIES CONTENTS Pages MANAGEMENT AND ADMINISTRATION 1 2 REPORT O
3、F THE MANAGER TO THE UNITHOLDERS 3 5 UNAUDITED FINANCIAL STATEMENTS Statements of financial position 6 Statements of profit or loss and other comprehensive income 7 8 Statements of changes in net assets attributable to unitholders 9 Statements of cash flows 10 11 INVESTMENT PORTFOLIO(UNAUDITED)12 MO
4、VEMENTS IN INVESTMENT PORTFOLIO(UNAUDITED)13 PERFORMANCE RECORD(UNAUDITED)14 DETAILS IN RESPECT OF FINANCIAL DERIVATIVE INSTRUMENTS(UNAUDITED)15 DISTRIBUTION DISCLOSURE(UNAUDITED)16 IMPORTANT:Any opinion expressed herein reflects the Managers view only and is subject to change.For more information a
5、bout the Products of the ChinaAMC Leveraged/Inverse Series,please refer to the prospectus of the ChinaAMC Leveraged/Inverse Series which is available at our website:http:/.hk/en/products.html?linkage_id=990351 Investors should not rely on the information contained in this report for their investment
6、 decisions.1 CHINAAMC LEVERAGED/INVERSE SERIES MANAGEMENT AND ADMINISTRATION Manager China Asset Management(Hong Kong)Limited 37/F,Bank of China Tower 1 Garden Road Central,Hong Kong Directors of the Manager Gan Tian Li Yimei Li Fung Ming Sun Liqiang Yang Kun Trustee and Registrar HSBC Institutional